On pathways and blind alleys-The importance of biomarkers in vitamin B
next generation sequencing
pyridoxal 5′-phosphate
pyridoxine
seizures
therapy-resistance
vitamin trial
Journal
Journal of inherited metabolic disease
ISSN: 1573-2665
Titre abrégé: J Inherit Metab Dis
Pays: United States
ID NLM: 7910918
Informations de publication
Date de publication:
09 2023
09 2023
Historique:
revised:
30
06
2023
received:
29
05
2023
accepted:
06
07
2023
medline:
8
9
2023
pubmed:
10
7
2023
entrez:
10
7
2023
Statut:
ppublish
Résumé
Over the past two decades, the field of vitamin B
Substances chimiques
Vitamin B 6
8059-24-3
Pyridoxine
KV2JZ1BI6Z
Pyridoxal Phosphate
5V5IOJ8338
Biomarkers
0
Vitamins
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
839-847Informations de copyright
© 2023 The Author. Journal of Inherited Metabolic Disease published by John Wiley & Sons Ltd on behalf of SSIEM.
Références
Hunt AD Jr, Stokes J Jr, McCrory WW, et al. Pyridoxine dependency: report of a case of intractable convulsions in an infant controlled by pyridoxine. Pediatrics. 1954;13:140-145.
Crowther LM, Mathis D, Poms M, Plecko B. New insights into human lysine degradation pathways with relevance to pyridoxine-dependent epilepsy due to antiquitin deficiency. J Inherit Metab Dis. 2019;42:620-628.
Plecko B, Stöckler-Ipsiroglu S, Paschke E, et al. Pipecolic acid elevation in plasma and cerebrospinal fluid of two patients with pyridoxine-dependent epilepsy. Annals of Neurology. 2000;48(1):121-125.
Plecko B, Hikel C, Korenke G-C, et al. Pipecolic acid as a diagnostic marker of pyridoxine-dependent epilepsy. Neuropediatrics. 2005;36(3):200-205.
Mills PB, Struys E, Jakobs C, et al. Mutations in antiquitin in individuals with pyridoxine-dependent seizures. Nat Med. 2006;12(3):307-309.
Farrant RD, Walker V, Mills GA, Mellor JM, Langley GJ. Pyridoxal phosphate de-activation by pyrroline-5-carboxylic acid. Increased risk of vitamin B6 deficiency and seizures in hyperprolinemia type II. J Biol Chem. 2001;276(18):15107-15116.
Struys EA, Jakobs C. Alpha-aminoadipic semialdehyde is the biomarker for pyridoxine dependent epilepsy caused by alpha-aminoadipic semialdehyde dehydrogenase deficiency. Mol Genet Metab. 2007;91(4):405.
Struys EA, Bok LA, Emal D, Houterman S, Willemsen MA, Jakobs C. The measurement of urinary Δ1-piperideine-6-carboxylate, the alter ego of α-aminoadipic semialdehyde, in antiquitin deficiency. J Inherit Metab Dis. 2012 Sep;35(5):909-916.
Boehm T, Hubmann H, Karin Petroczi K, et al. Condensation of delta-1-piperideine-6-carboxylate with ortho-aminobenzaldehyde allows its simple, fast, and inexpensive quantification in the urine of patients with antiquitin deficiency. J Inherit Metab Dis. 2020;43(4):891-900.
Mills PB, Surtees RA, Champion MP, et al. Neonatal epileptic encephalopathy caused by mutations in the PNPO gene encoding pyridox(am)ine 5′-phosphate oxidase. Hum Mol Genet. 2005;14(8):1077-1086.
Baumgartner-Sigl S, Haberlandt E, Mumm S, et al. Congenital hypophosphatasia caused by two novel missense mutations (c.677T>C, p.M226T; c.1112C>T, p.T371I) of the tissue-nonspecific alkaline phosphatase gene. Bone. 2007;40(6):1655-1661.
Plecko B, Stöckler S. Vitamin B6 dependent seizures. Can J Neurol Sci. 2009;36(Suppl 2):S73-S77.
Bräutigam C, Hyland K, Wevers R, et al. Clinical and laboratory findings in twins with neonatal epileptic encephalopathy mimicking aromatic L-amino acid decarboxylase deficiency. Neuropediatrics. 2002;33:113-117.
Levtova A, Camuzeaux S, Laberge AM, et al. Normal cerebrospinal fluid pyridoxal 5’-phosphate level in a PNPO-deficient patient with neonatal-onset epileptic encephalopathy. JIMD Rep. 2015;22:67-75.
Mathis D, Abela L, Albersen M, et al. The value of plasma vitamin B6 profiles in early onset epileptic encephalopathies. J Inherit Metab Dis. 2016;39(5):733-741.
Wilson MP, Plecko B, Mills PB, Clayton PT. Disorders affecting vitamin B6 metabolism. J Inherit Metab Dis. 2019;42:629-646.
Mills PB, Footitt EJ, Ceyhan S, et al. Urinary AASA excretion is elevated in patients with molybdenum cofactor deficiency and isolated sulphite oxidase deficiency. J Inherit Metab Dis. 2012;35(6):1031-1036.
Hyland K, Buist NRM, Powell BR, et al. Folinic acid responsive seizures: a new syndrome? J Inherit Metab Dis. 1995;18:177-181.
Gallagher RC, Van Hove JL, Scharer G, et al. Folinic acid-responsive seizures are identical to pyridoxine-dependent epilepsy. Ann Neurol. 2009;65(5):550-556.
Mohamed-Ahmed AHA, Wilson MP, Albuera M, et al. Quality and stability of extemporaneous pyridoxal phosphate preparations used in the treatment of paediatric epilepsy. J Pharm Pharmacol. 2017;69(4):480-488.
Stockler S, Plecko B, Gospe SM Jr, et al. Pyridoxine dependent epilepsy and antiquitin deficiency: clinical and molecular characteristics and recommendations for diagnosis, treatment and follow-up. Mol Genet Metab. 2011;104(1-2):48-60.
Sudarsanam A, Singh H, Wilcken B, et al. Cirrhosis associated with pyridoxal 5′-phosphate treatment of pyridoxamine 5′-phosphate oxidase deficiency. JIMD Rep. 2014;17:67-70.
Coman D, Lewindon P, Clayton P, et al. PNPO deficiency and cirrhosis: expanding the clinical phenotype? J Inherited Metab Dis Rep. 2016;25:71-75.
Webster R, Sankaran BP, Stormon M, et al. Liver transplantation in PNPO deficiency: management challenges and biological lessons. J Inherited Metab Dis. 2021;44.
Plecko B, Philippa Mills P. PNPO Deficiency. GeneReviews®. 2022.
Pearl PL, Gospe SM Jr. Pyridoxine or pyridoxal-5′-phosphate for neonatal epilepsy: the distinction just got murkier. Neurology. 2014;82(16):1392-1394.
Plecko B, Paul K, Mills P, et al. Pyridoxine responsiveness in novel mutations of the PNPO gene. Neurology. 2014;82:1425-1433.
Mills PB, Camuzeaux SS, Footitt EJ, et al. Epilepsy due to PNPO mutations: genotype, environment and treatment affect presentation and outcome. Brain. 2014;137:1350-1360.
Darin N, Reid E, Prunetti L, et al. Mutations in PROSC disrupt cellular pyridoxal phosphate homeostasis and cause vitamin-B6-dependent epilepsy. Am J Hum Genet. 2016;99:1325-1337.
Plecko B, Zweier M, Begemann A, et al. Confirmation of mutations in PROSC as a novel cause of vitamin B6-dependent epilepsy. J Med Genet. 2017;54:809-814.
Johnstone DL, Al-Shekaili HH, Tarailo-Graovac M, et al. PLPHP deficiency: clinical, genetic, biochemical, and mechanistic insights. Brain. 2019;142(3):542-559.
Al-Shekaili H, Ciapaite J, Karnebeek CV. Pena I. PLPBP Deficiency. GeneReviews® 2023.
van Karnebeek CD, Hartmann H, Jaggumantri S, et al. Lysine restricted diet for pyridoxine-dependent epilepsy: first evidence and future trials. Mol Genet Metab. 2012;107:335-344.
Mercimek-Mahmutoglu S, Cordeiro D, Cruz V, et al. Novel therapy for pyridoxine dependent epilepsy due to ALDH7A1 genetic defect: L-arginine supplementation alternative to lysine-restricted diet. Eur J Paediatr Neurol. 2014;18(6):741-746.
Coughlin CR 2nd, van Karnebeek CD, Al-Hertani W, et al. Triple therapy with pyridoxine, arginine supplementation and dietary lysine restriction in pyridoxine-dependent epilepsy: neurodevelopmental outcome. Mol Genet Metab. 2015;116:35-43.
Coughlin CRII, Tseng LA, Bok LA, et al. Association between lysine reduction therapies and cognitive outcomes in patients with pyridoxine dependent epilepsy. Neurology. 2022;99:e2627-e2636.
Coughlin CR 2nd, Tseng LA, Abdenur JE, et al. Consensus guidelines for the diagnosis and management of pyridoxine-dependent epilepsy due to α-aminoadipic semialdehyde dehydrogenase deficiency. J Inherit Metab Dis. 2021;44(1):178-192.
Al-Shekaili HH, Petkau TL, Pena I, et al. A novel mouse model for pyridoxine-dependent epilepsy due to antiquitin deficiency. Hum Mol Genet. 2020;29:3266-3284.
Pena IA, Roussel Y, Daniel K, et al. Pyridoxine-dependent epilepsy in zebrafish caused by Aldh7a1 deficiency. Genetics. 2017;207:1501-1518.
Zabinyakov N, Bullivant G, Cao F, et al. Characterization of the first knock-out aldh7a1 zebrafish model for pyridoxine-dependent epilepsy using CRISPR-Cas9 technology. PLoS One. 2017;12:e0186645.
Struys EA, Jansen EE, Salomons GS. Human pyrroline-5-carboxylate reductase (PYCR1) acts on Δ(1)-piperideine-6-carboxylate generating L-pipecolic acid. J Inherit Metab Dis. 2014;37(3):327-332.
Crowther LM, Poms M, Zandl-Lang M, et al. Metabolomics analysis of antiquitin deficiency in cultured human cells and plasma: relevance to pyridoxine-dependent epilepsy. J Inherit Metab Dis. 2023;46(1):129-142.
Engelke UF, van Outersterp RE, Merx J, et al. Untargeted metabolomics and infrared ion spectroscopy identify biomarkers for pyridoxine-dependent epilepsy. J Clin Invest. 2021;131:e148272.
Symonds JD, Amy MTA. Epilepsy and developmental disorders: next generation sequencing in the clinic. Eur J Paediatr Neurol. 2020;24:15-23.